XML 67 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash and restricted cash presented on our balance sheets to amounts shown in our consolidated statements of cash flows:

As of December 31,
202420232022
(in thousands)
Cash and cash equivalents
$132,818 $2,974 $— 
Restricted cash – current5,490 261 8,000 
Restricted cash – noncurrent102,600 5,494 7,304 
Total cash, cash equivalents and restricted cash$240,908 $8,729 $15,304 
Schedule of Restricted Cash and Restricted Cash Equivalents
The following table provides a reconciliation of cash and restricted cash presented on our balance sheets to amounts shown in our consolidated statements of cash flows:

As of December 31,
202420232022
(in thousands)
Cash and cash equivalents
$132,818 $2,974 $— 
Restricted cash – current5,490 261 8,000 
Restricted cash – noncurrent102,600 5,494 7,304 
Total cash, cash equivalents and restricted cash$240,908 $8,729 $15,304 
Schedules of Concentration of Risk by Revenue
The below purchasers represented greater than 10% of our revenues during the years ended December 31, 2024, 2023 and 2022:

202420232022
Shell Trading US Company23.7%18.3%20.8%
ConocoPhillips16.5%*15.1%
*Purchaser did not account for greater than 10% of revenue for the year
Schedule of Supplemental Cash Flow
The following are our supplemental cash flow disclosures for the years ended December 31, 2024, 2023 and 2022:

Year Ended December 31,
202420232022
(in thousands)
Supplemental cash flow disclosures:
Interest paid, net of amounts capitalized$141,760 $113,796 $81,920 
Income tax payments (refunds)
1,851 (1,391)8,164 
Non-cash investing and financing activities:
Capital expenditures included in accounts payable and accrued liabilities180,172 83,841 92,518 
Equity consideration for acquisitions
611,423 — — 
Right-of-use assets obtained in exchange for leases62,468 29,624 13,343